BMC Health Services Research, Vol 21, Iss 1, Pp 1-15 (2021) BMC Health Services Research Investigators, ISARICC & Dark, P 2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. ', BMC Health Services Research, vol. 21, no. 1, 566 . https://doi.org/10.1186/s12913-021-06509-x BMC HEALTH SERVICES RESEARCH 2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England ', BMC Health Services Research, vol. 21, no. 1, pp. 566 . https://doi.org/10.1186/s12913-021-06509-x
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5
Eurosurveillance Thompson, CP, Grayson, NE, Paton, RS, Bolton, JS, Lourenço, J, Penman, BS, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Simmonds, P & Dark, P 2020, ' Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020. ', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 25, no. 42 . https://doi.org/10.2807/1560-7917.es.2020.25.42.2000685 2020, ' Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 ', Eurosurveillance, vol. 25, no. 42 . https://doi.org/10.2807/1560-7917.ES.2020.25.42.2000685